Earlier identification is also of interest due to the possibility that earlier intervention may be more effective with more ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Depression is everywhere these days, but mental health professionals are not. Some alternative treatments that could help are ...

Compared with placebo, pramipexole added to antidepressants reduces symptoms significantly at 12 weeks in treatment-resistant depression, a trial finds.

The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...

Introduction Major depressive disorder (MDD) is a major global healthcare challenge. This is, in part, due to the lack of treatment response and chronic course of MDD. Such a course of illness is ...

Depression affects 1%-2% of children younger than 13 in the U.S. and can arise as early as age 3, but a specialized ...

Deep transcranial magnetic stimulation was safe and effective in treating adolescents and young adults with major depressive ...

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of ...

A first-of-its-kind clinical trial shows that ketamine treatment for severe, treatment-resistant depression is significantly ...

The government has permitted Dr. Cameron Lacey, a psychiatrist, to prescribe psilocybin, a hallucinogenic compound found in ...